Reported 2 days ago
Merit Medical Systems has acquired Biolife Delaware, a manufacturer of hemostatic devices, for approximately $120 million. The deal includes StatSeal and WoundSeal products aimed at stopping bleeding, and is expected to generate an additional $18 million in revenue next year. This acquisition is part of a broader strategy by Merit to pursue complementary product expansions, following previous acquisitions in the medical device sector.
Source: YAHOO